FDA NDC Directory · JSON-LD · Markdown

EMPLICITI

NDC 0003-2291 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameelotuzumab
Labeler / ManufacturerE.R. Squibb & Sons, L.L.C.
Marketing categoryBiologic License Application · App BLA761035
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsELOTUZUMAB (300 mg/1)
Marketing started20151130
Package count1

External sources

Source: openFDA. Public-domain (CC0).